About: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Medical Devices
Latest price: $79.93 (+1.67%)
DXCM NASDAQ DexCom Inc
DexCom Inc share price
Atividade de preço de DXCM
Último preço
$ 79,930
Variação (24h)
1,31 USD (1,67%)
Volume
5.91M
Volume (média 4 sem.)
-
Abertura
$ 79,08
Variação do dia
$ 78,59 - $ 80,01
Fechamento anterior
$ 78,62
Último negócio
29 Oct, 8:27 pm GMT+0
Atrasado
29 Oct, 8:27 pm GMT+0
DXCM price performance
Atrasado
29 Oct, 8:27 pm GMT+0
quote.marketSignals